Drug Information

Drug General Information
Drug ID
D07KEH
Former ID
DIB005678
Drug Name
AKB-6548
Indication Anemia [ICD9: 280-285; ICD10:D50-D64] Phase 2 [523526]
Company
Akebia therapeutics
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) HIF prolyl hydroxylase Target Info Modulator
References
Ref 523526ClinicalTrials.gov (NCT01381094) 42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.